Smith & Nephew has announced that the UK’s National Institute for Health and Clinical Excellence (NICE) has issued draft guidance supporting the case for utilising the Exogen Ultrasound Bone Healing System. It’s now putting its draft findings out for consultation.
The first clinical trial resulting from NICE medical technology guidance recommendations is due to start soon on a device to promote wound healing.
UK NICE’s guidance on clinical management of Peripheral Artery Disease patients is comprehensive and says they should not be “offered” major amputation unless all other attempts to revascularise have been considered. Strange language, but we know what you mean.
NICE, the healthcare guidance body, has today issued guidance supporting the use of Covidien’s Pipeline® device for the treatment of complex brain aneurysms.
NICE endorses vac-assisted PleurX drainage system for treatment-resistant ascites patients.
UK’s healthcare institute, NICE, has issued updated guidelines on practices designed to reduce healthcare associated infections from their current staggering number.
Safety, cost-effectiveness and quality are the key parameters that lie behind NICE’s approval of four new-generation cardiac computed tomography (CT) scanners for use by the NHS in Coronary Artery Disease patients.
Recent news flow from both sides of the Atlantic has reinforced the case for speeding up the rate which UK Medtech company Deltex Medical Group’s CardioQ-ODM device is adopted, according to research house Equity Development.
The UK’s National Health Service has issued guidelines for the company’s ExAblate focused ultrasound device for the removal of uterine fibroids.
UK’s National Institute for Health and Clinical Excellence has found that use of PleurX’s peritoneal catheter drainage system is suported by evidence.
UK’s National Institute for Clinical Excellence(NICE) states in a new article that charities are urging people who may be at risk of developing COPD should visit their doctor and have a spirometry test in order to get an early diagnosis of the condition.
Latest findings, presented at the NCRI Cancer Conference in Liverpool, UK, highlight the positive impact that the NICE referral guideline for suspected cancer has had since its launch in 2005.
UK’s NICE has published diagnostic guidance encouraging the use of the EOS 2D/3D imaging system in specialist research settings.
Bayer Schering Pharma welcome NICE’s Final Appraisal Determination giving a draft recommendation that Xarelto (rivaroxaban), within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective total hip or elective total knee replacement surgery.